Response to 'Cure for Mantle Cell Lymphoma Within Reach'Response to 'Cure for Mantle Cell Lymphoma Within Reach'

Researchers not involved in the current research contest the characterization of bendamustine and rituximab as a "salvage" therapy, among other concerns. Letters to the Editor
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news